Clinical Trials Logo
  1. Home
  2. Septic Shock
  3. NCT06121115
  4. Details
NCT06121115 Clinical Trial

Norepinephrine Administration Through a Midline Catheter in an Intermediate Care Unit

Septic Shock Clinical Trial

Official title:
Norepinephrine Administration Through a Midline Catheter in an Intermediate Care Unit - a Retrospective Study of Complications and Patient Outcomes

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT06121115
Other study ID # 2022-06476
Secondary ID
Status Completed
Phase
First received
Last updated
Start date October 3, 2023
Est. completion date March 1, 2024

Study information
Verified date March 2024
Source Region Skane
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This is a single-center study retrospectively evaluating a local clinical routine to administer norepinephrine in midline catheters, with regard to complications and patient outcomes

Description:

Se attached study protocol

Recruitment information / eligibility
Status Completed
Enrollment 473
Est. completion date March 1, 2024
Est. primary completion date March 1, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Administration of norepinephrine in a midline catheter in an intermediary care unit - In Skåne university hospital - From 2019 to 2023-03-31 Exclusion Criteria: - Patients who have actively disabled review of their electronic medical record

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• Norepinephrine
Norepinephrine administered in midline catheter according to clinical routine

Locations
Country Name City State
Sweden Skåne University Hospital Malmö

Sponsors (1)
Lead Sponsor Collaborator
Region Skane

Country where clinical trial is conducted

Sweden, 

Outcome
Type Measure Description Time frame Safety issue
Primary Proportion of patients with a major complication of norepinephrine administration in midline extravasation of norepinephrine, midline-associated bloodstream infection, thrombosis day 30
Secondary Proportion of patients with a minor complication of norepinephrine administration in midline infiltration, occlusion of midline, dislodgement, leakage, other day 30
Secondary Proportion of patients receiving a CVC after midline Has the patient received central line after midline placement day 30
Secondary Proportion of patients with different intermediary care unit outcomes Where did the patient go after intermediary care? discharged / escalated to the ICU / deceased day 30
See also
  Status Clinical Trial Phase
Recruiting NCT03649633 - Vitamin C, Steroids, and Thiamine, and Cerebral Autoregulation and Functional Outcome in Septic Shock Phase 1/Phase 2
Terminated NCT04117568 - The Role of Emergency Neutrophils and Glycans in Postoperative and Septic Patients
Completed NCT04227652 - Control of Fever in Septic Patients N/A
Completed NCT05629780 - Temporal Changes of Lactate in CLASSIC Patients N/A
Recruiting NCT04796636 - High-dose Intravenous Vitamin C in Patients With Septic Shock Phase 1
Terminated NCT03335124 - The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock Phase 4
Recruiting NCT04005001 - Machine Learning Sepsis Alert Notification Using Clinical Data Phase 2
Recruiting NCT05217836 - Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
Recruiting NCT05066256 - LV Diastolic Function vs IVC Diameter Variation as Predictor of Fluid Responsiveness in Shock N/A
Not yet recruiting NCT05443854 - Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01) Phase 3
Not yet recruiting NCT04516395 - Optimizing Antibiotic Dosing Regimens for the Treatment of Infection Caused by Carbapenem Resistant Enterobacteriaceae N/A
Recruiting NCT02899143 - Short-course Antimicrobial Therapy in Sepsis Phase 2
Recruiting NCT02565251 - Volemic Resuscitation in Sepsis and Septic Shock N/A
Recruiting NCT02676427 - Fluid Responsiveness in Septic Shock Evaluated by Caval Ultrasound Doppler Examination
Recruiting NCT02580240 - Administration of Hydrocortisone for the Treatment of Septic Shock N/A
Completed NCT02638545 - Hemodynamic Effects of Dexmedetomidine in Septic Shock Phase 3
Terminated NCT02335723 - ASSET - a Double-Blind, Randomized Placebo-Controlled Clinical Investigation With Alteco® LPS Adsorber N/A
Not yet recruiting NCT02547467 - TOADS Study: TO Assess Death From Septic Shock. N/A
Completed NCT02204852 - Co-administration of Iloprost and Eptifibatide in Septic Shock Patients Phase 2
Completed NCT02079402 - Conservative vs. Liberal Approach to Fluid Therapy of Septic Shock in Intensive Care Phase 4